The wellness industry is buzzing with a new player in the GLP-1 market, and it’s not a pharmaceutical giant—it’s Pura Collagen, a brand that’s turning heads with its ‘pure’ hormone-stimulating alternative. But here’s where it gets controversial: can a collagen-based product really compete with prescription medications in managing glucose levels and appetite? Let’s dive in.
This January 2026, Pura Collagen launched GLPure+ powder, a game-changer in their lineup, marking their seventh product in just five years. Each serving packs a whopping 5,000mg of Nextida GC, a patented collagen peptide from Rousselot. Clinically proven to stimulate the body’s natural GLP-1 hormone response, this ingredient is a powerhouse for reducing post-meal glucose spikes by up to 43% (https://pmc.ncbi.nlm.nih.gov/articles/PMC11606891/). But that’s not all—GLPure+ is paired with a metabolism-boosting blend, including chromium for macronutrient metabolism and blood glucose control (https://www.sciencedirect.com/science/article/abs/pii/S0273230097911363), vitamin C for fatigue reduction and collagen formation (https://pubmed.ncbi.nlm.nih.gov/18505499/), and zinc for carbohydrate metabolism (https://www.sciencedirect.com/science/article/pii/S0002916523023535).
Jennifer Mo, Pura Collagen’s founder, revealed that the inspiration behind GLPure+ came from a surge in customer inquiries about GLP-1 medications and their side effects, particularly concerns about skin integrity and the dreaded ‘Ozempic face.’ ‘Customers were asking if collagen could complement these medications,’ she explained. ‘We always advise consulting a GP, but the demand sparked our interest in exploring non-pharmaceutical alternatives.’ And this is the part most people miss: Mo’s decision was also fueled by emerging research showing Nextida GC’s ability to activate intestinal L- and K-cells, boosting incretin hormones like GLP-1 and GIP, which are crucial for glucose regulation and appetite control (https://pmc.ncbi.nlm.nih.gov/articles/PMC11606891/).
But Pura Collagen didn’t stop there. Tapping into the booming digestive health market—projected to skyrocket from $51.7 billion in 2023 to $106.47 billion by 2032—they launched Pura Digest. This innovative product targets bloating, irregularity, and digestive discomfort with 5g of hydrolyzed collagen peptides, clinically shown to strengthen the gut lining and combat leaky gut syndrome (https://pubmed.ncbi.nlm.nih.gov/28174772/). It’s paired with Biotis GOS for microbiota balance (https://www.sciencedirect.com/science/article/pii/S0023643824015743), calcium for digestive enzyme function, and vitamin C for immune support and collagen production. Developed after in-house research revealed that 44% of consumers struggle with gut issues and 59% seek prebiotic and probiotic solutions, Pura Digest is designed to fortify the gut barrier and support overall digestive health.
Mo’s journey with Pura began in 2021, when she co-founded the brand with just two products: ‘Glow+’ and ‘Flex+’, targeting skin, hair, nails, and bone health. Fast forward to today, their lineup includes ‘Sleep’ (with magnesium, l-tryptophan, and zinc), ‘Balance’ (hormone-focused with ashwagandha, soy isoflavones, and more), and ‘Protect’ (immunity-boosting with ginger root extract). Available in the UK, Benelux, and Dubai, with Switzerland on the horizon for March 2026, Pura remains committed to its core philosophy: keeping products as close to their raw, pure form as possible. ‘We’re not about overcomplicating things,’ Mo emphasized. However, they’re also prioritizing convenience, with GLPure+ available in individual sachets for on-the-go use, and plans to trial portable formats across their range in Holland & Barrett Benelux.
What’s next for Pura? Mo is confident that collagen’s potential is just being tapped. ‘Collagen isn’t going anywhere,’ she said. ‘But the real excitement lies in bioactive collagen peptides and the research exploring their applications across various conditions.’ This optimism is backed by Pura’s acquisition by Vector Consumer Ltd in 2024 (https://www.nutraingredients.com/Article/2024/04/15/health-brand-builder-vector-consumer-ltd-acquires-pura-collagen/), which provided the financial stability and resources to scale up. ‘It gave us the breathing space to innovate without constraints,’ Mo noted.
Controversial Question: Can collagen-based solutions like GLPure+ truly rival pharmaceutical GLP-1 medications in effectiveness and safety? Or is this just a niche alternative for those wary of traditional drugs? Share your thoughts below—we’d love to hear your take on this evolving debate!
